logo
Plus   Neg
Share
Email

Varian Medical Systems To Buy Cancer Treatment Services For $283 Mln

Varian Medical Systems (VAR) Monday said it has agreed to acquire Cancer Treatment Services International for $283 million.

The privately held CTSI operates the American Oncology Institute in Hyderabad and 10 multidisciplinary—radiation, medical and surgical oncology— cancer centers across the Indian subcontinent as well as a U.S.-based Oncology Solutions division that provides cancer care professional services to healthcare providers worldwide.

The deal is expected to accelerate identification of unmet clinical and operational needs to facilitate advances in technology and services.

"At Varian, the patient and clinician are at the center of our thinking as we evolve into a broad-based cancer care solutions company," said Dow Wilson, president and chief executive officer of Varian. "Our acquisition of CTSI is consistent with this strategy and will allow us to better support oncology centers globally, accelerate access to technology-driven care and build a feedback loop that will drive cost-effective innovation."

Varian plans to fund the deal with a combination of borrowings under its credit facility and cash on hand. The transaction is anticipated to close in about two weeks.

Looking forward, Varian now expects full year 2019 earnings of $4.55 to $4.70 per share and revenues of $3.09 to $3.18 billion. Previously, the company expected earnings of $4.60 to $4.75 per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Department of Justice has reached a settlement agreement with a Texas-based Taco Bell franchise owner for immigration-related discrimination against certain employees. The settlement resolves the DOJ's investigation into whether MUY Brands LLC, and a related management company, MUY Consulting Inc., violated the Immigration and Nationality Act. Starbucks is gearing up for the upcoming holiday season by introducing its 2019 holiday flavors in U.S. grocery stores. The launch of the coffee giant's holiday line-up this year includes returning holiday favorites as well as a new item. Customers can now take home products that are making a comeback such as Starbucks Holiday Blend K-Cup and Ground Coffee, Peppermint Mocha Flavored Ground Coffee, Peekay International issued a recall of 7 ounce and 14 ounce packs containing Keshav Dry Apricot food treats as they contain undeclared allergens such as sulfites, according to a statement published by The U.S. Food and Drug Administration. Consumption of the product by those allergic or having severe sensitivity to sulfites could run the risk of serious or life-threatening allergic reactions.
RELATED NEWS
Follow RTT
>